Valentina Zanuso

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Replacement Therapy

Metastatic Renal Cell Carcinoma

Top Venues

Clinical liver disease

Journal of hepatocellular carcinoma

Expert opinion on investigational drugs

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Zanuso, Angelo Pirozzi, Giulia Tesini, Lorenza Rimassa
Review of immune therapy in HCC: Where are we now and what is the future? Clinical liver disease 23 (1) (2024)
Valentina Zanuso, Angelo Pirozzi, Giulia Tesini, Lorenza Rimassa
Review of immune therapy in HCC: Where are we now and what is the future? Clinical liver disease 23 (1) (2024)
Valentina Zanuso, Angelo Pirozzi, Rita Balsano, Tiziana Pressiani, Lorenza Rimassa
Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Silvia Bozzarelli, Nicola Personeni, Lorenza Rimassa
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
Nicola Personeni, Tiziana Pressiani, Valentina Zanuso, Andrea Casadei-Gardini, Antonio D'Alessio, Martina Valgiusti, Vincenzo Dadduzio, Francesca Bergamo, Caterina Soldà, Mario Domenico Rizzato, Laura Giordano, Armando Santoro, Lorenza Rimassa
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment. Journal of personalized medicine 12 (10) (2022)
Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights. Journal of hepatocellular carcinoma 9 (2022)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
Antonio D'Alessio, Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma. Expert review of anticancer therapy 21 (9) (2021)
Maria Giuseppina Prete, Antonella Cammarota, Antonio D'Alessio, Valentina Zanuso, Lorenza Rimassa
Current options and future directions of systemic therapy for advanced biliary tract cancer. Exploration of targeted anti-tumor therapy 2 (5) (2021)